Brazilian Industry Policy After 1990: Focusing on the Pharmaceutical Industry
Política Industrial Brasileña después de 1990: Focalización sobre la Industria Farmaceutica.;
Política Industrial Brasileira pós 1990: A Indústria Farmacêutica em Questão
Author
Da Silva, Christian Luiz
Oliveira, Alexandre
Abstract
The present article analyses the active principle and drug sector in Brazil after 1990. It has five sections showing that, at that time, the government priority was to maintain economic stability to the detriment of strengthening national drug industry. The article analyses the actions implemented through projects and concluded that the results of such policy were not satisfactory. Results show that the country continues to depend on multinational companies which control and progress vertical and horizontally in all stages of drug production to developing countries, thus benefiting from competitive advantages. Finally, it points out the measures needed for Brazil to join the active principle and drug international market. The present article analyses the active principle and drug sector in Brazil after 1990. It has five sections showing that, at that time, the government priority was to maintain economic stability to the detriment of strengthening national drug industry. The article analyses the actions implemented through projects and concluded that the results of such policy were not satisfactory. Results show that the country continues to depend on multinational companies which control and progress vertical and horizontally in all stages of drug production to developing countries, thus benefiting from competitive advantages. Finally, it points out the measures needed for Brazil to join the active principle and drug international market. Este artigo analisa o desenvolvimento do setor de fármacos e medicamentos, no Brasil, após 1990. Em cinco seções, mostra-se que a prioridade do governo foi a estabilidade econômica, em detrimento do fortalecimento da indústria farmacêutica nacional. Analisam-se as ações implementadas, em função dos projetos idealizados, para se chegar à conclusão de que os resultados foram insatisfatórios. Argumenta-se que o país continua dependente das empresas multinacionais que conseguem dominar, verticalizar e horizontalizar todos os estágios da produção de remédios para os países em desenvolvimento, obtendo vantagens competitivas.Finalmente, apontam-se providências necessárias para inserir o Brasil no mercado de fármacos e medicamentos internacional.